Clinical Trials Logo

Filter by:
NCT ID: NCT06209840 Recruiting - Cerebral Palsy Clinical Trials

The Effect of Music Therapy on Upper Extremity Functions and Quality Of Life in Individuals With Cerebral Palsy

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The main purpose of this study is to investigate the effect of music therapy on the upper extremity functions and quality of life of individuals with Cerebral Palsy (CP). The secondary aim is to investigate the effect of music therapy on the sensory functions of the upper extremity in individuals with CP. Adolescent individuals with hemiparetic CP will participate in this study, and the participants will experience music therapy, which is a scientific intervention approach. If music therapy has a positive effect on upper extremity functions, they will be more active in daily life and their quality of life will increase. In the light of these data to be presented, a contribution will be made to the evidence level of music therapy in the literature and to the content of SP upper extremity rehabilitation.

NCT ID: NCT06209762 Recruiting - Clinical trials for Mechanical Low Back Pain

Investigation of the Effects of Inspiratory Muscle Training on Patients With Mechanical Low Back Pain.

Start date: December 26, 2023
Phase: N/A
Study type: Interventional

There are many conservative treatment methods for the treatment of mechanical low back pain and they continue to be developed. The aim of this study is to examine the effects of inspiratory muscle training, which can be added to these treatment methods, on muscle endurance, functional capacity, pain intensity, disability, quality of life and sleep quality in people with mechanical low back pain.

NCT ID: NCT06209736 Recruiting - C3 Glomerulopathy Clinical Trials

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Start date: March 1, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of OMS906 in patients with C3 Glomerulopathy (C3G) and Idiopathic Immune Complex-Mediated Glomerulonephritis (ICGN)

NCT ID: NCT06209658 Recruiting - Clinical trials for Breastfeeding Self-efficacy

Breastfeeding Education Given to Primiparous Mothers With the Teach-Back Method

Start date: October 18, 2023
Phase: N/A
Study type: Interventional

The Teach-Back method was initially developed as a communication technique for patients to remember important information about their diagnosis, treatment or medication and to understand what to do. Method; It requires recalling and explaining any information learned during the interaction between the healthcare team and clients. It has been seen that the use of the tell-what-you-learned method can be used effectively in increasing the learning and comprehension level of individuals who lack health knowledge, contributing to positive health behaviors and reducing the return to health institutions, and it has begun to be used in different areas that require patient education. There are no examples of studies in which the tell-what-you-learned method, which has been brought to the agenda and implemented abroad in recent years, is used in our country. The development of breastfeeding self-efficacy is a very challenging process. Postpartum anxiety occurs in women with low breastfeeding self-efficacy perception. Different training methods are used to initiate and maintain breastfeeding. However, there is no generally accepted method that can bridge the communication gap between patients and healthcare professionals and can be used in health education. It is important to use the tell-what-you-learned method, which is used in patient/client training and is expressed as a communication technique based on expressing what the caregivers have learned in their own words, as it is not enough for the individuals being cared for to say "I understand", in terms of increasing the success of breastfeeding and improving the health of the mother and baby.

NCT ID: NCT06209489 Recruiting - Clinical trials for Hyperbilirubinemia, Neonatal

White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

This study aimed to examine the effect of white cover and massage application on newborns' bilirubin level and duration of phototherapy in newborns receiving phototherapy.

NCT ID: NCT06209333 Recruiting - Clinical trials for Overactive Bladder Syndrome (OABS)

Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS

OABS/BT/PFET
Start date: October 15, 2023
Phase: N/A
Study type: Interventional

The aim of this study was to examine the effects of bladder training and pelvic floor exercise training programs given in addition to Botulinum Toxin-A (BTx-A) application on urinary symptoms and quality of life in patients with Overactive Bladder Syndrome (AAMS) who do not respond to conservative treatments. Individuals who meet the criteria for inclusion in the study and agree to participate in the study will be divided into 2 separate research branches.The patients to be included in the study will be divided into two groups as "Group 1=Botox + physiotherapy " or "Group 2=Botox group ". In addition to the BTx-A application, bladder training and pelvic floor exercise training will be applied to patients in the first group, while standard patient training will be provided to patients in the second group. Severity of urinary symptoms, quality of life and subjective perception of improvement Before BTx-A application, 2 weeks and 12 weeks after BTX-A application, International Incontinence Consultation Questionnaire - Women's Lower Urinary Tract Symptoms (ICIQ-FLUTS), 1-hour ped test, International Incontinence Consultation- Lower Urinary Tract Symptoms Quality of Life Scale (ICIQ-LUTS) and Global Perception of Improvement will be evaluated.

NCT ID: NCT06209060 Recruiting - Behavior, Child Clinical Trials

Hammock Position and Nesting in the Neonatal Intensive Care Unit

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This research aims to determine the effect of hammock position and nesting practices on the comfort level and physiological parameters of preterm babies.

NCT ID: NCT06209034 Recruiting - Clinical trials for Intracranial Pressure Increase

Intraoperative Optic Nerve Sheath Diameter Changes After Laparoscopic Surgery

Start date: December 30, 2023
Phase: N/A
Study type: Interventional

Laparoscopic surgery is a widely used alternative to open surgery; Advantages include reduced bleeding and pain intensity, shorter hospital stay, and improved cosmetic results. Laparoscopic surgery involves the creation of a carbon dioxide (CO2) pneumoperitoneum to facilitate a clear surgical view, which can result in increased intracranial pressure (ICP). Ultrasonographic measurement of optic nerve sheath diameter (ONSD) is a simple, non-invasive, yet reliable technique for ICP assessment.Ultrasonographic assessment of optic nerve sheath diameter (ONSD) has been proposed as a non-invasive measurement of intracranial pressure.

NCT ID: NCT06208215 Recruiting - Clinical trials for Congenital Hyperinsulinism

RZ358 Treatment for Congenital Hyperinsulinism

sunRIZE
Start date: January 11, 2024
Phase: Phase 3
Study type: Interventional

The Phase 3 pivotal study is designed to evaluate the efficacy and safety of RZ358 for the treatment of congenital hyperinsulinism (HI) as add-on to standard-of-care (SOC) therapy compared to SOC alone over 24 weeks and to evaluate the longer-term safety and efficacy of RZ358 during a subsequent open-label extension (OLE) period.

NCT ID: NCT06208150 Recruiting - Clinical trials for Relapsed or Refractory Multiple Myeloma

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

MonumenTAL-6
Start date: January 22, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of either talquetamab plus pomalidomide (Tal-P) or talquetamab plus teclistamab (Tal-Tec) with elotuzumab, pomalidomide, and dexamethasone (EPd) or pomalidomide, bortezomib, and dexamethasone (PVd).